Please use this identifier to cite or link to this item: https://doi.org/10.1016/S0928-0987(02)00148-3
DC FieldValue
dc.titleEffect of 5-fluorouracil on the anticoagulant activity and the pharmacokinetics of warfarin enantiomers in rats
dc.contributor.authorZhou, Q.
dc.contributor.authorChan, E.
dc.date.accessioned2014-10-29T01:51:44Z
dc.date.available2014-10-29T01:51:44Z
dc.date.issued2002-10
dc.identifier.citationZhou, Q., Chan, E. (2002-10). Effect of 5-fluorouracil on the anticoagulant activity and the pharmacokinetics of warfarin enantiomers in rats. European Journal of Pharmaceutical Sciences 17 (1-2) : 73-80. ScholarBank@NUS Repository. https://doi.org/10.1016/S0928-0987(02)00148-3
dc.identifier.issn09280987
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/105864
dc.description.abstractThe interaction between the antineoplastic agent 5-fluorouracil (5-FU) and the oral anticoagulant warfarin enantiomers was investigated in rats. An increase in hypoprothrombinaemic response, assessed by means of percent changes of prothrombin complex activity and clotting factor VII activity, to warfarin, was observed following oral administration of 1.5 mg/kg racemic warfarin to rats during a 8-day intraperitoneal dose regimen of 5-FU (13.3 mg/kg daily). 5-FU had no apparent effect on the baseline blood coagulation, the in vitro rat serum protein binding as well as the absorption and distribution of the S- and R-enantiomers of warfarin in rats. Yet treatment with 5-FU produced a significant decrease in the total serum clearance value of S-warfarin in rats. The decreased total clearance was attributed mainly to a significant decrease in the formation rate of the overall oxidative metabolites of the more potent S-enantiomer of warfarin. © 2002 Elsevier Science B.V. All rights reserved.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1016/S0928-0987(02)00148-3
dc.sourceScopus
dc.subject5-Fluorouracil
dc.subjectPharmacodynamics
dc.subjectPharmacokinetics
dc.subjectStereoselective drug interactions
dc.subjectWarfarin
dc.typeArticle
dc.contributor.departmentPHARMACY
dc.description.doi10.1016/S0928-0987(02)00148-3
dc.description.sourcetitleEuropean Journal of Pharmaceutical Sciences
dc.description.volume17
dc.description.issue1-2
dc.description.page73-80
dc.description.codenEPSCE
dc.identifier.isiut000178785100008
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.